Summary
- Current Price
- As of today, KALV price is $26.73, up +0.06% in the most recent trading session on
- Current Price All-Time High
- KALV price is currently -79.30% below its historical high of $129.11 set on
- Market Cap
- KALV current market cap is $1B, up +134.44% over the past 365 days
- PE Ratio
- KALV PE ratio is unknown
- Revenue
- KALV current annual revenue is $73.62M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for KALV is on
Profile
| Metric | Value |
|---|---|
| Full Name | KalVista Pharmaceuticals, Inc. |
| Ticker | NASDAQ: KALV |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kalvista.com |
| Employees | 270 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $26.73 | |
| Price, 1D Change | +0.06% | |
| $1B | ||
| - | ||
| - | ||
| 0.74 | ||
| $74M | ||
| Revenue, 1Y Change | +100.00% | |
| -$3.23 | ||
| EPS, 1Y Change | +12.64% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:14 | |
| Next Split | N/A | N/A |
| Last Ticker Change | CBYL | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.23 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $73.62M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $26.73 | |
| Price Target | - | $27.00 |
| Price Tgt. Change | - | +1.03% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| -$0.80 | N/A | +75.08% | |
| -$2.79 | N/A | +13.56% | |
| $1.20 | N/A | +137.18% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| $206.44M | N/A | +180.43% | |
| $120.70M | N/A | +63.96% | |
| $329.20M | N/A | +347.18% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $26.73 | |
| $15.40 | ||
| SMA 200 vs Price | -42.37% | |
| $19.89 | ||
| SMA 50 vs Price | -25.57% | |
| 0.74 | ||
| $0.94 | ||
| 75.31 | ||
| 193.56% | ||
| 73.73% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $73.62M | ||
| -$3.23 | ||
| $69.00M | ||
| 91.75% | ||
| -$168.06M | ||
| -233.42% | ||
| -$164.29M | ||
| -223.16% | ||
| -$170.39M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 5.58 | ||
| 5.52 | ||
| - | ||
| - | ||
| -1.16 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 18.93 | ||
| -524.13 | ||
| -11.29 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$2.71M | ||
| $300.21M | ||
| $335.38M | ||
| $320.15M | ||
| $338.09M | ||
| $57.36M | ||
| $284.21M | ||
| $15.19M | ||
| $8.27M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $237.90M | ||
| $237.05M | ||
| $4.62M | ||
| $0.00 | ||
| $969.00K | ||
| $0.00 | ||
| -$1.55M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$81.62M | ||
| $18.68M | ||
| $162.64M | ||
| $1.90M | ||
| -$83.52M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Needham | → | |
| Stifel | → | |
| Citizens | → | |
| Needham | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Needham | → | |
| Citizens | → |
Analyst sentiment
Institutional ownership
Screeners with KALV
FAQ
What is the ticker symbol for KalVista Pharmaceuticals, Inc.?
The ticker symbol for KalVista Pharmaceuticals, Inc. is NASDAQ:KALV
Does KalVista Pharmaceuticals, Inc. pay dividends?
No, KalVista Pharmaceuticals, Inc. does not pay dividends
What sector is KalVista Pharmaceuticals, Inc. in?
KalVista Pharmaceuticals, Inc. is in the Healthcare sector
What industry is KalVista Pharmaceuticals, Inc. in?
KalVista Pharmaceuticals, Inc. is in the Biotechnology industry
What country is KalVista Pharmaceuticals, Inc. based in?
KalVista Pharmaceuticals, Inc. is headquartered in United States
When did KalVista Pharmaceuticals, Inc. go public?
KalVista Pharmaceuticals, Inc. initial public offering (IPO) was on April 9, 2015
Is KalVista Pharmaceuticals, Inc. in the S&P 500?
No, KalVista Pharmaceuticals, Inc. is not included in the S&P 500 index
Is KalVista Pharmaceuticals, Inc. in the NASDAQ 100?
No, KalVista Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is KalVista Pharmaceuticals, Inc. in the Dow Jones?
No, KalVista Pharmaceuticals, Inc. is not included in the Dow Jones index
When was KalVista Pharmaceuticals, Inc. last earnings report?
KalVista Pharmaceuticals, Inc.'s most recent earnings report was on November 10, 2025
When does KalVista Pharmaceuticals, Inc. report earnings?
The next expected earnings date for KalVista Pharmaceuticals, Inc. is May 15, 2026
Data Sources & References
- KALV Official Website www.kalvista.com
- KALV Profile on Yahoo Finance finance.yahoo.com/quote/KALV
- KALV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/kalv